The Mechanism of Action of cTIND for Minimally Invasive Ischemic Incision of the Prostate: In Vivo Study - ScienceDirect

$ 22.99

5 (357) In stock

Immunoproteasome inhibition prevents progression of castration

Acute and late toxicity and preliminary outcomes report of

Ultrastructure, synaptic organization, and molecular components of

PDF) 'Minimum-incision' endoscopically assisted transvesical

The Mechanism of Action of cTIND for Minimally Invasive Ischemic

Minimally Invasive Surgical Approaches and Management of Prostate

Epigenetic mechanisms underlying prostate cancer radioresistance

Minimally Invasive Surgical Approaches and Management of Prostate

Multifunctional nano-system for multi-mode targeted imaging and

Immunoproteasome inhibition prevents progression of castration-resistant prostate cancer

ISBN: 978-1-7344916-1-6 This book is intended to help pathologists survive when faced with prostate pathology problems. It provides a practical

Survival Guide to Prostate Pathology | Innovative Science Press

In-vivo and in-silico studies revealed the molecular mechanisms of

Unlocking the Future of mCRPC Treatment: Exploring Immune

DDX52 knockdown inhibits the growth of prostate cancer cells by